Skip to main content

Peer Review reports

From: Modeling the potential economic benefits of an oral SARS-CoV-2 vaccine during an outbreak of COVID-19

Original Submission
18 Apr 2022 Submitted Original manuscript
7 Jun 2022 Reviewed Reviewer Report
31 Jul 2022 Reviewed Reviewer Report
5 Aug 2022 Author responded Author comments - Bryan Patenaude
Resubmission - Version 2
5 Aug 2022 Submitted Manuscript version 2
Publishing
8 Sep 2022 Editorially accepted
22 Sep 2022 Article published 10.1186/s12889-022-14148-y

You can find further information about peer review here.

Back to article page